Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.
Glyco-lipopeptides, a form of lipid-tailed glyco-peptide, are currently under intense investigation as B- and T-cell based vaccine immunotherapy for many cancers. However, the cellular and molecular mechanisms of glyco-lipopeptides (GLPs) immunogenicity and the position of the lipid moiety on immuno...
Main Authors: | Olivier Renaudet, Gargi Dasgupta, Ilham Bettahi, Alda Shi, Anthony B Nesburn, Pascal Dumy, Lbachir BenMohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2888579?pdf=render |
Similar Items
-
Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Editorial: Insights into glyco-parasitology
by: Kentaro Kato, et al.
Published: (2024-05-01) -
Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
by: Latifa Zayou, et al.
Published: (2025-02-01) -
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
by: Pierre-Gregoire Coulon, et al.
Published: (2024-03-01)